Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
A progressive leader among House Democrats on lowering drug prices is circulating a letter calling for “necessary improvements” to Speaker Nancy Pelosi’s (D-Calif.) signature legislation on the topic.
Premiums for Medicare Advantage plans are expected to decline next year by 14% compared with 2019 as plans aim to offer more choices, according to the Centers for Medicare & Medicaid Services (CMS).
The Trump administration is taking major political heat for opposing Obamacare in a high-stakes legal challenge, which a federal appeals court could rule on any day now.
The backers of alternative legislation to address the red-hot “surprise medical bill” issue just got a surprise bill of their own from the Congressional Budget Office.
Kaiser Health News is suing the U.S. Centers for Medicare & Medicaid Services to release dozens of audits that the agency says reveal hundreds of millions of dollars in overcharges by Medicare Advantage health plans.
The thrill of delivering newborns helped pull Dr. Jack Feltz into the field of obstetrics and gynecology. More than 30 years later, he still enjoys treating patients, he said. But now, Feltz is also working to change the way doctors are paid for maternity care.
The majority of voters in a new poll supports a health care plan that would expand a public option but maintain the private insurance industry.
Californians who lost the option to automatically re-enroll in an Affordable Care Act exchange plan were less likely to hold on to their insurance coverage than households that could enroll automatically, according to a study published Monday in JAMA Internal Medicine.
Twenty-five Southern California doctors and others are accused of billing Medicare and other health plans for $150 million in fraudulent charges.
Many Republicans were quick to criticize House Speaker Nancy Pelosi’s new proposal to reduce drug prices. President Trump wasn’t one of them. Soon after the California Democrat released her drug-price bill Thursday, Trump said in a tweet that it was “great to see Speaker Pelosi’s bill.”